Aktie 002872 TIANSHENG PHARMACEUTICAL GROUP CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tiansheng Pharmaceutical Group Co., Ltd.

Aktien

002872

CNE100002QC3

002872

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 17.05.2024 		% 5 Tage % 1. Jan.
4.35 CNY +0.23% Intraday Chart für Tiansheng Pharmaceutical Group Co., Ltd. +4.07% -15.20%
2023 Tiansheng Pharmaceutical Group Co., Ltd. kündigt Ernennungen von Führungskräften an CI
2023 Tiansheng Pharmaceutical Group Co., Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments
Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center
Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Chongqing Pharmaceutical CO., LTD. completed the acquisition of 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd..
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021
Tiansheng Pharmaceutical Group Co., Ltd. Approves Election of Directors
An unknown buyer acquired 11% stake in Hubei Xianming Medical Apparatus and Instruments Co., Ltd. from Hubei Xianming Medical Apparatus and Instruments Co., Ltd. for CNY 5.1 million.
An unknown buyer acquired Chongqing Xinmei Pharmaceutical Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 0.
Chongqing Pharmaceutical CO., LTD. signed an equity transfer intention agreement to acquire 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 59.6 million.
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd.
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Junyao Pharmaceutical Packing Products Co., Ltd. from Chen Yi and Feng Yi.
Tiansheng Pharmaceutical Group Co., Ltd. Announces 2017 Final Distribution Plan, Payable on August 22, 2018
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002872 Aktie
  4. Nachrichten Tiansheng Pharmaceutical Group Co., Ltd.
  5. Andere Sprachen